Clinical Trials Logo

Clinical Trial Summary

The investigators study is to investigate safety and efficacy of performing a planned incomplete removal of large acoustic neuroma tumors to decrease surgical morbidity and yet avoid tumor recurrence by post-operative radiation therapy.


Clinical Trial Description

The current standard treatment of a large tumor of the balance nerve (acoustic neuroma or vestibular schwannoma) is surgical resection. Complete removal of such tumor is associated with significant risks of hearing loss and facial paralysis whereas incomplete removal of the tumor is associated with significant risks of regrowth. Stereotactic radiation is a well accepted therapy aiming at stopping the growth of smaller acoustic neuromas before their sizes become large enough to cause problems. The purpose of our study is to determine whether the combination of subtotal resection followed by stereotactic radiation of the remnant can control large acoustic neuromas without the significant risks associated with complete resection. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01129687
Study type Observational
Source Stanford University
Contact
Status Completed
Phase
Start date March 2005
Completion date May 8, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04101409 - Impact of Shared Decision-Making With Decision Aids on Acoustic Neuroma Treatment Choice: A Randomized Controlled Trial N/A
Recruiting NCT03970681 - Clinical and Radiological Evaluation of Acoustic Neuromas With Spontaneous Shrinkage
Terminated NCT01345136 - Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma Phase 2